Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551014 · ClinicalTrials.gov registry record · NA
Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT04551014: Completed NA study, sponsored by Stanford University.
NCT04551014 is a NA study that has completed, run by Stanford University. The registered enrollment target is 158 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04551014, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
The focus of the study is to evaluate impact of submucosal injection of EverLift in achieving complete resection during polypectomy of polyps 4-9mm during colonoscopy.
Interventions
- DEVICE Use of EverLift
- DEVICE Without use of EverLift
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2020-09-16 |
| Est. Completion | 2021-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04551014
The ClinicalTrials.gov registry entry for NCT04551014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Use of EverLift is the first listed.
NCT04551014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04551014 about?
NCT04551014 is a clinical study titled "Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm". The focus of the study is to evaluate impact of submucosal injection of EverLift in achieving complete resection during polypectomy of polyps 4-9mm during colonoscopy.
What is the current status of trial NCT04551014?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2020-09-16. Estimated completion is 2021-07-15.
What interventions are being tested in trial NCT04551014?
The interventions under investigation include: Use of EverLift (DEVICE), Without use of EverLift (DEVICE).
Who is sponsoring clinical trial NCT04551014?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.